| 417 |
Post TAVR PCI & Commissure Alignment |
Nicolas M. Van Mieghem |
Aug. 07. 23 |
| 416 |
Evolut PRO+ Feature & Latest Clinical Datas Related to Access |
Han Cheol Lee |
Aug. 07. 23 |
| 415 |
My Experience on ACURATE neo2 and Its Applications for Lifetime Management |
Won-Keun Kim |
Aug. 07. 23 |
| 414 |
ACURATE neo2 Experience at SNUH and Comparing with Current Clinical Outcomes |
Jeehoon Kang |
Aug. 07. 23 |
| 413 |
ACURATE neo2: Optimized Features and Benefits for TAVI Patients in Korea |
Jung-Joon Cha |
Aug. 07. 23 |
| 412 |
Taiwan Challenging Case |
Shih-Hsien Sung |
Aug. 04. 23 |
| 411 |
Japan Challenging Case |
Shunsuke Kubo |
Aug. 04. 23 |
| 410 |
Korea Challenging Case |
Geu-Ru Hong |
Aug. 04. 23 |
| 409 |
Sharing Experiences on Why I Choose SAPIEN 3 for a Better Outcome |
Wei-Hsian Yin |
Aug. 04. 23 |
| 408 |
Planning and Working with SAPIEN 3 Ultra |
Karl Poon |
Aug. 04. 23 |
